OAC
RIGL icon

OMERS Administration Corp’s Rigel Pharmaceuticals RIGL Stock Holding History

OMERS Administration Corp’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.03M Buy
51,900
+23,300
+81% +$719K 0.01% 561
2026
Q1 		$773K Buy
+28,600
New +$961K 0.01% 702
2025
Q4 		– Sell
-12,000
Closed -$340K – 1284
2025
Q3 		$340K Buy
+12,000
New +$359K ﹤0.01% 845

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OMERS Administration Corp's RIGL Position: Q2 2026 in Review

OMERS Administration Corp increased its Rigel Pharmaceuticals (RIGL) stake by 81% in Q2 2026, buying an estimated $719K and bringing the position to 51,900 shares worth $2.03M. The position accounts for 0.01% of the portfolio, ranked #561.

OMERS Administration Corp first reported a position in RIGL in Q3 2025 and has held it in 3 quarters since. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • OMERS Administration Corp held 51,900 shares of Rigel Pharmaceuticals worth $2.03M as of Q2 2026.
  • OMERS Administration Corp bought 23,300 Rigel Pharmaceuticals shares in Q2 2026, an estimated $719K.
  • Rigel Pharmaceuticals made up 0.01% of OMERS Administration Corp's portfolio in Q2 2026, its #561 holding.
  • OMERS Administration Corp first reported a position in Rigel Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.